Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis.

MLA

Cheng, David, et al. “Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis.” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 39, no. 7, July 2019, pp. 1448–57. EBSCOhost, https://doi.org/10.1161/ATVBAHA.119.312725.

APA

Cheng, D., Talib, J., Stanley, C. P., Rashid, I., Michaëlsson, E., Lindstedt, E.-L., Croft, K. D., Kettle, A. J., Maghzal, G. J., & Stocker, R. (2019). Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 39(7), 1448–1457. https://doi.org/10.1161/ATVBAHA.119.312725

Chicago

Cheng, David, Jihan Talib, Christopher P Stanley, Imran Rashid, Erik Michaëlsson, Eva-Lotte Lindstedt, Kevin D Croft, Anthony J Kettle, Ghassan J Maghzal, and Roland Stocker. 2019. “Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis.” Arteriosclerosis, Thrombosis, and Vascular Biology 39 (7): 1448–57. doi:10.1161/ATVBAHA.119.312725.